<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04557696</url>
  </required_header>
  <id_info>
    <org_study_id>19-012188</org_study_id>
    <nct_id>NCT04557696</nct_id>
  </id_info>
  <brief_title>A Study to Implement and Evaluate REFLECT Communication Curriculum for Oncology Based Medical Graduate Students</brief_title>
  <official_title>Implementation and Prospective Evaluation of the REFLECT Communication Curriculum for Oncology Based Medical Graduate Students</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mayo Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mayo Clinic</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to collect data from quarterly workshops (standardized patient&#xD;
      simulations, reflective narratives, questionnaires, surveys, standardized patient and peer&#xD;
      feedback, and participant critiques) of participants enrolled in oncology-based residencies&#xD;
      and fellowships will be collected. The information that is gathered from this study will be&#xD;
      used to describe this population that participate in the workshop and see whether or not&#xD;
      introduction of a communication curriculum alongside with the training program will improve&#xD;
      communication, self-awareness, and interpersonal skills over time.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Resident/fellow feedback indicated study factors made it difficult to participate and busy&#xD;
    schedules did not accommodate to consent.&#xD;
  </why_stopped>
  <start_date type="Actual">August 18, 2020</start_date>
  <completion_date type="Actual">February 24, 2021</completion_date>
  <primary_completion_date type="Actual">February 24, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Emotional Intelligence</measure>
    <time_frame>Baseline, annually through study completion approximately 10 years</time_frame>
    <description>Change in emotional intelligence comparing baseline scores on the ESCI (Emotional and Social Competence Inventory) with scores on annual ESCI reassessments.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">4</enrollment>
  <condition>Medical Trainees in Oncology Programs</condition>
  <arm_group>
    <arm_group_label>Control Group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Standard oncology curriculum for medical trainees in oncology programs.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Reflective Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Standard oncology curriculum with standardized patient simulation, in addition to the REFLECT Curriculum workshops for medical trainees in oncology programs.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>REFLECT Curriculum</intervention_name>
    <description>Annual quarterly workshops will consist of guest lecturers, role playing, patient panels, coaching, knowledge assessments, Standardized Patient (SP) simulations and debriefing/feedback sessions.</description>
    <arm_group_label>Reflective Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Subjects: Resident or Fellow enrolled in an oncology related training program&#xD;
             (Radiation Oncology, Medical Oncology, Palliative Medicine and Hospice Care,&#xD;
             Neurooncology).&#xD;
&#xD;
          -  Location: Mayo Clinic Arizona.&#xD;
&#xD;
          -  Interest: Willingness to participate.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Schedule does not permit to participation.&#xD;
&#xD;
          -  Not enrolled in an oncology-based residency or fellowship at Mayo Clinic Arizona.&#xD;
&#xD;
          -  Interest: Not willing to participate.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Tamara Vern-Gross, DO, FAAP</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mayo Clinic</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Mayo Clinic in Arizona</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85054</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>https://www.mayo.edu/research/clinical-trials</url>
    <description>Mayo Clinic Clinical Trials</description>
  </link>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>September 15, 2020</study_first_submitted>
  <study_first_submitted_qc>September 15, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">September 22, 2020</study_first_posted>
  <last_update_submitted>October 20, 2021</last_update_submitted>
  <last_update_submitted_qc>October 20, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 25, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mayo Clinic</investigator_affiliation>
    <investigator_full_name>Tamara Z. Vern-Gross</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

